Paper23948699
Targeting MicroRNAs for personalized cancer therapy.
Li Y and 4 others. Med Princ Pract, 2013. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Targeting MicroRNAs for personalized cancer therapy. Papers, record 23948699. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948699
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| Neoplastic Stem Cells | Major topic |
| Precision Medicine | Major topic |
| Humans | |
| Oligonucleotides |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 CA108535 | NCI NIH HHS | United States | R01CA108535 | PubMed and NIH |
Source NIH RePORTER
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21948564 | MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells. | Stem Cells | 2011 | https://conductscience.org/library/papers/21948564 | PubMed |
| 2 | 16258535 | Silencing of microRNAs in vivo with 'antagomirs'. | Nature | 2005 | https://conductscience.org/library/papers/16258535 | PubMed |
| 3 | 22966018 | Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22966018 | PubMed |
| 4 | 22579961 | The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22579961 | PubMed |
| 5 | 22552290 | miRNA-708 control of CD44(+) prostate cancer-initiating cells. | Cancer Res | 2012 | https://conductscience.org/library/papers/22552290 | PubMed |
| 6 | 23042614 | Personalized medicine benefits patients in early trials: matching targeted therapies with gene mutations is associated with better outcomes, even in phase 1 studies. | Cancer | 2012 | https://conductscience.org/library/papers/23042614 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39218619 | MicroRNAs implicated in canine diffuse large B-cell lymphoma prognosis. | FEBS Open Bio | 2024 | https://conductscience.org/library/papers/39218619 | PubMed |
| 38970040 | The interplay between microRNAs and Nrf2 signaling in human cancers. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38970040 | PubMed |
| 33552829 | MiR-192-5p regulates the proliferation and apoptosis of cholangiocarcinoma cells by activating MEK/ERK pathway. | 3 Biotech | 2021 | https://conductscience.org/library/papers/33552829 | PubMed |
| 30544100 | miR-192 Is Overexpressed and Promotes Cell Proliferation in Prostate Cancer. | Med Princ Pract | 2019 | https://conductscience.org/library/papers/30544100 | PubMed |
| 29327732 | A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. | Acta Otorhinolaryngol Ital | 2017 | https://conductscience.org/library/papers/29327732 | PubMed |
| 26228733 | Novel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers. | Med Princ Pract | 2016 | https://conductscience.org/library/papers/26228733 | PubMed |
| 25243170 | The potential of microRNAs in personalized medicine against cancers. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25243170 | PubMed |
| 25196201 | Oligometastatic non-small cell lung cancer: a significant entity outside of specialized cancer centers? | Med Princ Pract | 2014 | https://conductscience.org/library/papers/25196201 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23948699
GET https://conductscience.org/api/papers/v1/23948699/authors